UniProt ID | CAAP1_HUMAN | |
---|---|---|
UniProt AC | Q9H8G2 | |
Protein Name | Caspase activity and apoptosis inhibitor 1 | |
Gene Name | CAAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 361 | |
Subcellular Localization | ||
Protein Description | Anti-apoptotic protein that modulates a caspase-10 dependent mitochondrial caspase-3/9 feedback amplification loop.. | |
Protein Sequence | MTGKKSSREKRRKRSSQEAAAALAAPDIVPALASGSSGSTSGCGSAGGCGSVSCCGNANFSGSVTGGGSGGSCWGGSSVERSERRKRRSTDSSSVSGSLQQETKYILPTLEKELFLAEHSDLEEGGLDLTVSLKPVSFYISDKKEMLQQCFCIIGEKKLQKMLPDVLKNCSIEEIKKLCQEQLELLSEKKILKILEGDNGMDSDMEEEADDGSKMGSDLVSQQDICIDSASSVRENKQPEGLELKQGKGEDSDVLSINADAYDSDIEGPCNEEAAAPEAPENTVQSEAGQIDDLEKDIEKSVNEILGLAESSPNEPKAATLAVPPPEDVQPSAQQLELLELEMRARAIKALMKAGDIKKPA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MTGKKSSREKRRK --CCCCHHHHHHHHH | 37.81 | 20068231 | |
7 | Phosphorylation | -MTGKKSSREKRRKR -CCCCHHHHHHHHHH | 54.03 | 20068231 | |
44 | Ubiquitination | SGSTSGCGSAGGCGS CCCCCCCCCCCCCCC | 24.85 | 32015554 | |
58 | Phosphorylation | SVSCCGNANFSGSVT CEECCCCCCCCCCCC | 12.06 | 32142685 | |
89 | Phosphorylation | SERRKRRSTDSSSVS HHHHHHCCCCCCCCC | 40.37 | 23927012 | |
90 | Phosphorylation | ERRKRRSTDSSSVSG HHHHHCCCCCCCCCH | 37.78 | 22167270 | |
92 | Phosphorylation | RKRRSTDSSSVSGSL HHHCCCCCCCCCHHH | 25.30 | 22167270 | |
93 | Phosphorylation | KRRSTDSSSVSGSLQ HHCCCCCCCCCHHHH | 37.25 | 22167270 | |
94 | Phosphorylation | RRSTDSSSVSGSLQQ HCCCCCCCCCHHHHH | 25.01 | 25159151 | |
96 | Phosphorylation | STDSSSVSGSLQQET CCCCCCCCHHHHHHH | 25.31 | 23927012 | |
98 | Phosphorylation | DSSSVSGSLQQETKY CCCCCCHHHHHHHEE | 18.59 | 23927012 | |
103 | Phosphorylation | SGSLQQETKYILPTL CHHHHHHHEEEHHHH | 25.47 | 23403867 | |
104 | Sumoylation | GSLQQETKYILPTLE HHHHHHHEEEHHHHH | 29.55 | 28112733 | |
105 | Phosphorylation | SLQQETKYILPTLEK HHHHHHEEEHHHHHH | 18.34 | 27642862 | |
109 | Phosphorylation | ETKYILPTLEKELFL HHEEEHHHHHHHHHH | 44.07 | 24173317 | |
120 | Phosphorylation | ELFLAEHSDLEEGGL HHHHEECCCCCCCCC | 35.08 | 27422710 | |
155 | Ubiquitination | QQCFCIIGEKKLQKM HHHHHHHCHHHHHHH | 22.28 | 29967540 | |
167 | Phosphorylation | QKMLPDVLKNCSIEE HHHCHHHHHCCCHHH | 4.26 | 32142685 | |
176 | Acetylation | NCSIEEIKKLCQEQL CCCHHHHHHHHHHHH | 42.86 | 27452117 | |
187 | Phosphorylation | QEQLELLSEKKILKI HHHHHHHCCHHHHHH | 61.05 | 23663014 | |
189 | 2-Hydroxyisobutyrylation | QLELLSEKKILKILE HHHHHCCHHHHHHHH | 41.56 | - | |
189 | Acetylation | QLELLSEKKILKILE HHHHHCCHHHHHHHH | 41.56 | 26051181 | |
189 | Ubiquitination | QLELLSEKKILKILE HHHHHCCHHHHHHHH | 41.56 | 32015554 | |
190 | Ubiquitination | LELLSEKKILKILEG HHHHCCHHHHHHHHC | 49.58 | - | |
203 | Phosphorylation | EGDNGMDSDMEEEAD HCCCCCCCCCHHHCC | 29.93 | 22167270 | |
213 | Phosphorylation | EEEADDGSKMGSDLV HHHCCCCCCCCHHHH | 26.85 | 20363803 | |
217 | Phosphorylation | DDGSKMGSDLVSQQD CCCCCCCHHHHHHCC | 25.03 | 22777824 | |
221 | Phosphorylation | KMGSDLVSQQDICID CCCHHHHHHCCEEEE | 29.44 | 17525332 | |
229 | Phosphorylation | QQDICIDSASSVREN HCCEEEECHHHHHHC | 15.33 | 27251275 | |
231 | Phosphorylation | DICIDSASSVRENKQ CEEEECHHHHHHCCC | 33.06 | 27251275 | |
232 | Phosphorylation | ICIDSASSVRENKQP EEEECHHHHHHCCCC | 25.55 | 27251275 | |
256 | Phosphorylation | GEDSDVLSINADAYD CCCCCCEEEECCCCC | 17.41 | 29802988 | |
262 | Phosphorylation | LSINADAYDSDIEGP EEEECCCCCCCCCCC | 19.27 | 28348404 | |
264 | Phosphorylation | INADAYDSDIEGPCN EECCCCCCCCCCCCC | 28.01 | 30257219 | |
300 | Ubiquitination | DLEKDIEKSVNEILG HHHHHHHHHHHHHHH | 61.10 | 29967540 | |
301 | Phosphorylation | LEKDIEKSVNEILGL HHHHHHHHHHHHHHH | 19.86 | 25159151 | |
311 | Phosphorylation | EILGLAESSPNEPKA HHHHHHHCCCCCCCC | 45.55 | 22167270 | |
312 | Phosphorylation | ILGLAESSPNEPKAA HHHHHHCCCCCCCCE | 24.21 | 19664994 | |
349 | Acetylation | EMRARAIKALMKAGD HHHHHHHHHHHHHCC | 34.19 | 12436885 | |
349 | Ubiquitination | EMRARAIKALMKAGD HHHHHHHHHHHHHCC | 34.19 | - | |
353 | Acetylation | RAIKALMKAGDIKKP HHHHHHHHHCCCCCC | 50.49 | 12436895 | |
359 | Acetylation | MKAGDIKKPA----- HHHCCCCCCC----- | 46.65 | 12436905 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
203 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAAP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAAP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
XRCC4_HUMAN | XRCC4 | physical | 16169070 | |
KAT7_HUMAN | KAT7 | physical | 16169070 | |
PTN_HUMAN | PTN | physical | 16169070 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-312, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-90; SER-92; SER-94;SER-203 AND SER-312, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-312, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. |